{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T16:42:46Z","timestamp":1786207366100,"version":"build-2736575974"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Managing branch-duct intraductal papillary mucinous neoplasms (BD-IPMNs) remains challenging, as guideline criteria (worrisome features\/high-risk stigmata) and nomograms often leave uncertainty. Next-generation sequencing (NGS) may provide actionable molecular information that influences clinical decision-making.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a national, vignette-based decision-impact study involving 132 clinicians (gastroenterologists and surgeons). Four complex BD-IPMN vignettes (each with two to four worrisome features) were evaluated twice: pre-NGS and post-NGS after disclosure of either a high-risk mutation (positive) or its absence (negative). The primary endpoint was the within-physician change in management in the NGS-concordant direction (NGS+ surveillance to surgery; NGS\u2212 surgery to surveillance) assessed using McNemar\u2019s test and mixed-effects logistic regression. Secondary endpoints included change in decision confidence, inter-physician agreement (Fleiss\u2019 \u03baappa), and practitioner factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      NGS significantly changed management in all vignettes (all\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.001): with NGS\u2212, surgical plans shifted to surveillance (43% in distal pancreatectomy; 61% in pancreatoduodenectomy scenarios); with NGS+, surveillance shifted to surgery (90% and 72%, respectively; both\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.001). In mixed-model, post-NGS reduced surgery in NGS\u2212 cases (odd ratio [OR] 0.30, 95%confidence interval [CI] 0.16\u20130.57) and the post-NGS effect was strongly amplified in NGS+ cases (interaction OR 76.51, 95%CI 26.47\u2013221.13). Population-averaged probabilities of choosing surgery shifted from 20% to 7% (NGS\u2212) and 42% to 94% (NGS+). Decision confidence increased (proportional-odds OR 4.66, 95%CI 3.62\u20136.02,\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.0001). Inter-physician agreement rose from\n                      <jats:italic>\u03ba<\/jats:italic>\n                      = 0.044 (95%CI 0.033\u20130.055) pre-NGS to\n                      <jats:italic>\u03ba<\/jats:italic>\n                      = 0.590 (95%CI 0.580\u20130.601) post-NGS (\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 2\u00d710\n                      <jats:sup>\u221216<\/jats:sup>\n                      ). After NGS, practitioner characteristics no longer explained decision patterns.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In complex BD-IPMN scenarios, NGS significantly influences clinician decision-making and reduces inter-physician variability. These findings support its role as a decision-support tool.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1245\/s10434-026-20023-6","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T16:41:35Z","timestamp":1782319295000},"page":"8459-8467","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of Next-Generation Sequencing on Surgical Decision-Making in Branch-Duct IPMN"],"prefix":"10.1245","volume":"33","author":[{"given":"Maxime","family":"Remy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremie","family":"Albouys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J\u00e9r\u00e9mie","family":"Birnbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastien","family":"Gaujoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Laure","family":"V\u00e9die","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9mence","family":"Descourvi\u00e8res","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Michel","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Lorenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"key":"20023_CR1","doi-asserted-by":"publisher","unstructured":"Elmadani M, Mokaya PO, Omer AAA, Kiptulon EK, Klara S, Orsolya M. Cancer burden in Europe: a systematic analysis of the GLOBOCAN database (2022). BMC Cancer [Internet]. 12 mars 2025 [cit\u00e9 13 juill 2025];25(1). Disponible sur: https:\/\/bmccancer.biomedcentral.com\/articles\/https:\/\/doi.org\/10.1186\/s12885-025-13862-1","DOI":"10.1186\/s12885-025-13862-1"},{"issue":"1","key":"20023_CR2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.21871","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin janv. 2025;75(1):10\u201345.","journal-title":"CA Cancer J Clin janv."},{"key":"20023_CR3","doi-asserted-by":"crossref","unstructured":"De La Fuente J, Chatterjee A, Lui J, Nehra AK, Bell MG, Lennon RJ, et al. Long-term outcomes and risk of pancreatic cancer in intraductal papillary mucinous neoplasms. JAMA Netw Open. 17 oct 2023 6(10):e2337799.","DOI":"10.1001\/jamanetworkopen.2023.37799"},{"issue":"2","key":"20023_CR4","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.pan.2023.12.009","volume":"24","author":"T Ohtsuka","year":"2024","unstructured":"Ohtsuka T, Fernandez-del Castillo C, Furukawa T, Hijioka S, Jang JY, Lennon AM, et al. International evidence-based Kyoto guidelines for the management of intraductal papillary mucinous neoplasm of the pancreas. Pancreatology mars. 2024;24(2):255\u201370.","journal-title":"Pancreatology mars"},{"key":"20023_CR5","doi-asserted-by":"crossref","unstructured":"European Study Group on Cystic Tumours of the Pancreas. European evidence-based guidelines on pancreatic cystic neoplasms. Gut. mai 2018;67(5):789\u2011804.","DOI":"10.1136\/gutjnl-2018-316027"},{"issue":"6","key":"20023_CR6","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1097\/XCS.0000000000000176","volume":"234","author":"P Zelga","year":"2022","unstructured":"Zelga P, Hernandez-Barco YG, Qadan M, Ferrone CR, Kambadakone A, Horick N, et al. Number of worrisome features and risk of malignancy in intraductal papillary mucinous neoplasm. J Am Coll Surg juin. 2022;234(6):1021\u201330.","journal-title":"J Am Coll Surg juin."},{"issue":"6","key":"20023_CR7","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1097\/SLA.0000000000001985","volume":"266","author":"JY Jang","year":"2017","unstructured":"Jang JY, Park T, Lee S, Kim Y, Lee SY, Kim SW, et al. Proposed nomogram predicting the individual risk of malignancy in the patients with branch duct type intraductal papillary mucinous neoplasms of the pancreas. Ann Surg d\u00e9c. 2017;266(6):1062\u20138.","journal-title":"Ann Surg d\u00e9c."},{"key":"20023_CR8","doi-asserted-by":"crossref","unstructured":"Jung W, Park T, Kim Y, Park H, Han Y, He J, et al. Validation of a nomogram to predict the risk of cancer in patients with intraductal papillary mucinous neoplasm and main duct dilatation of 10 mm or less. Br J Surg. 20 nov 2019 106(13):1829\u201136.","DOI":"10.1002\/bjs.11293"},{"issue":"16","key":"20023_CR9","doi-asserted-by":"publisher","first-page":"16958","DOI":"10.1002\/cam4.6326","volume":"12","author":"X Huang","year":"2023","unstructured":"Huang X, Guo T, Zhang Z, Cai M, Guo X, Zhang J, et al. Prediction of malignant intraductal papillary mucinous neoplasm: a nomogram based on clinical information and radiological outcomes. Cancer Med ao\u00fbt. 2023;12(16):16958\u201371.","journal-title":"Cancer Med ao\u00fbt."},{"issue":"1","key":"20023_CR10","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/SLA.0000000000003108","volume":"272","author":"Y Shimizu","year":"2020","unstructured":"Shimizu Y, Hijioka S, Hirono S, Kin T, Ohtsuka T, Kanno A, et al. New model for predicting malignancy in patients with intraductal papillary mucinous neoplasm. Ann Surg juill. 2020;272(1):155\u201362.","journal-title":"Ann Surg juill."},{"issue":"2","key":"20023_CR11","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s13304-021-00999-4","volume":"73","author":"R Casadei","year":"2021","unstructured":"Casadei R, Ricci C, Ingaldi C, Cornacchia A, Migliori M, Di Marco M, et al. External validation of nomogram for predicting malignant intraductal papillary mucinous neoplasm (IPMN): from the theory to the clinical practice using the decision curve analysis model. Updat Surg avr. 2021;73(2):429\u201338.","journal-title":"Updat Surg avr."},{"issue":"1","key":"20023_CR12","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1097\/SLA.0000000000002015","volume":"267","author":"MA Attiyeh","year":"2018","unstructured":"Attiyeh MA, Fern\u00e1ndez-del Castillo C, Al Efishat M, Eaton AA, G\u00f6nen M, Batts R, et al. Development and validation of a multi-institutional preoperative nomogram for predicting grade of dysplasia in intraductal papillary mucinous neoplasms (IPMNs) of the pancreas: a report from the pancreatic surgery consortium. Ann Surg janv. 2018;267(1):157\u201363.","journal-title":"Ann Surg janv."},{"issue":"5","key":"20023_CR13","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1097\/SLA.0000000000002399","volume":"266","author":"O Farges","year":"2017","unstructured":"Farges O, Bendersky N, Truant S, Delpero JR, Pruvot FR, Sauvanet A. The theory and practice of pancreatic surgery in France. Ann Surg. 2017;266(5):797\u2013804.","journal-title":"Ann Surg."},{"issue":"8","key":"20023_CR14","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/j.pan.2024.11.006","volume":"24","author":"H Belfrage","year":"2024","unstructured":"Belfrage H, Boyd S, Louhimo J, Kyt\u00f6l\u00e4 S, Johansson K, Tenca A, et al. Next-generation sequencing improves diagnostic accuracy of imaging and carcinoembryonic antigen alone for pancreatic cystic neoplasms. Pancreatology d\u00e9c. 2024;24(8):1322\u201331.","journal-title":"Pancreatology d\u00e9c."},{"issue":"1","key":"20023_CR15","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1053\/j.gastro.2022.09.028","volume":"164","author":"A Paniccia","year":"2023","unstructured":"Paniccia A, Polanco PM, Boone BA, Wald AI, McGrath K, Brand RE, et al. Prospective, multi-institutional, real-time next-generation sequencing of pancreatic cyst fluid reveals diverse genomic alterations that improve the clinical management of pancreatic cysts. Gastroenterology janv. 2023;164(1):117-133.e7.","journal-title":"Gastroenterology janv."},{"issue":"4","key":"20023_CR16","doi-asserted-by":"publisher","first-page":"e789","DOI":"10.1097\/SLA.0000000000005904","volume":"278","author":"MN Nikiforova","year":"2023","unstructured":"Nikiforova MN, Wald AI, Spagnolo DM, Melan MA, Grupillo M, Lai YT, et al. A Combined DNA\/RNA-based next-generation sequencing platform to improve the classification of pancreatic cysts and early detection of pancreatic cancer arising from pancreatic cysts. Ann Surg. 2023;278(4):e789\u201397.","journal-title":"Ann Surg."},{"key":"20023_CR17","doi-asserted-by":"crossref","unstructured":"Biswas S, Afrose S, Mita MA, Hasan MdR, Shimu MstSS, Zaman S, et al. Next\u2010generation sequencing: an advanced diagnostic tool for detection of pancreatic disease\/disorder. JGH Open. nov 2024 8(11):e70061.","DOI":"10.1002\/jgh3.70061"},{"issue":"12","key":"20023_CR18","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1136\/gutjnl-2016-313586","volume":"67","author":"AD Singhi","year":"2018","unstructured":"Singhi AD, McGrath K, Brand RE, Khalid A, Zeh HJ, Chennat JS, et al. Preoperative next-generation sequencing of pancreatic cyst fluid is highly accurate in cyst classification and detection of advanced neoplasia. Gut d\u00e9c. 2018;67(12):2131\u201341.","journal-title":"Gut d\u00e9c."},{"issue":"3","key":"20023_CR19","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1053\/j.gastro.2018.10.029","volume":"156","author":"Y Omori","year":"2019","unstructured":"Omori Y, Ono Y, Tanino M, Karasaki H, Yamaguchi H, Furukawa T, et al. Pathways of progression from intraductal papillary mucinous neoplasm to pancreatic ductal adenocarcinoma based on molecular features. Gastroenterology f\u00e9vr. 2019;156(3):647-661.e2.","journal-title":"Gastroenterology f\u00e9vr."},{"issue":"3","key":"20023_CR20","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1136\/gutjnl-2021-326550","volume":"72","author":"ST Liffers","year":"2023","unstructured":"Liffers ST, Godfrey L, Frohn L, Haeberle L, Yavas A, Vesce R, et al. Molecular heterogeneity and commonalities in pancreatic cancer precursors with gastric and intestinal phenotype. Gut mars. 2023;72(3):522\u201334.","journal-title":"Gut mars."},{"key":"20023_CR21","doi-asserted-by":"publisher","unstructured":"Singhi AD, Wald AI, Smith K, Wolkenstein L, Bubar RD, Diaz-Aragon R, et al. PancreaSeq genomic classifier (PancreaSeq GC) improves pancreatic cyst classification and detection of advanced neoplasia: a multi-institutional validation study. Ann Surg Oncol [Internet]. 12 d\u00e9c 2025 [cit\u00e9 19 d\u00e9c 2025]; Disponible sur: https:\/\/link.springer.com\/https:\/\/doi.org\/10.1245\/s10434-025-18848-8","DOI":"10.1245\/s10434-025-18848-8"},{"key":"20023_CR22","doi-asserted-by":"crossref","unstructured":"Lorenzo D, Aguilera Munoz L, Vedie AL, Prat F, Dokmak S, Sauvanet A, et al. Mural nodules and prevalence of high-grade dysplasia in branch duct intraductal papillary mucinous neoplasm of the pancreas undergoing resection. Br J Surg. 27 nov 2024 111(12):znae292.","DOI":"10.1093\/bjs\/znae292"},{"issue":"10","key":"20023_CR23","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1111\/hpb.12305","volume":"16","author":"AM Roch","year":"2014","unstructured":"Roch AM, Ceppa EP, DeWitt JM, Al-Haddad MA, House MG, Nakeeb A, et al. International Consensus Guidelines parameters for the prediction of malignancy in intraductal papillary mucinous neoplasm are not properly weighted and are not cumulative. HPB. 2014;16(10):929\u201335.","journal-title":"HPB."},{"issue":"4","key":"20023_CR24","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1177\/2050640615623370","volume":"4","author":"EPC Robles","year":"2016","unstructured":"Robles EPC, Maire F, Cros J, Vullierme MP, Rebours V, Sauvanet A, et al. Accuracy of 2012 International Consensus Guidelines for the prediction of malignancy of branch-duct intraductal papillary mucinous neoplasms of the pancreas. United Eur Gastroenterol J ao\u00fbt. 2016;4(4):580\u20136.","journal-title":"United Eur Gastroenterol J ao\u00fbt."},{"issue":"2","key":"20023_CR25","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.gie.2025.01.005","volume":"102","author":"AR Jones","year":"2025","unstructured":"Jones AR, Bardhi O, Polanco P, Ellis D, Bishop C, Coleman V, et al. Clinical utility of incorporating next-generation sequencing results in the management algorithm of pancreatic cysts. Gastrointest Endosc ao\u00fbt. 2025;102(2):223-232.e3.","journal-title":"Gastrointest Endosc ao\u00fbt."},{"key":"20023_CR26","doi-asserted-by":"crossref","unstructured":"Licata L, Viale G, Giuliano M, Curigliano G, Chavez-MacGregor M, Foldi J, et al. Oncotype DX results increase concordance in adjuvant chemotherapy recommendations for early-stage breast cancer. NPJ Breast Cancer. 8 juin 2023;9(1):51.","DOI":"10.1038\/s41523-023-00559-6"},{"issue":"11","key":"20023_CR27","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1038\/bjc.2013.207","volume":"108","author":"S Holt","year":"2013","unstructured":"Holt S, Bertelli G, Humphreys I, Valentine W, Durrani S, Pudney D, et al. A decision impact, decision conflict and economic assessment of routine Oncotype DX testing of 146 women with node-negative or pNImi, ER-positive breast cancer in the UK. Br J Cancer juin. 2013;108(11):2250\u20138.","journal-title":"Br J Cancer juin."},{"key":"20023_CR28","doi-asserted-by":"crossref","unstructured":"Chowdhury R, Hier J, Payne KE, Abdulhaleem M, Dimitstein O, Eisenbach N, et al. Impact of molecular testing on surgical decision-making in indeterminate thyroid nodules: a systematic review and meta-analysis of recent advancements. Cancers. 29 mars 2025 17(7):1156.","DOI":"10.3390\/cancers17071156"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20023-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-20023-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20023-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T15:48:56Z","timestamp":1786204136000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-026-20023-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["20023"],"URL":"https:\/\/doi.org\/10.1245\/s10434-026-20023-6","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,24]]},"assertion":[{"value":"23 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"There are no conflicts of interest to declare. This studty did not receive any financial support from the public, private or not-for-profit sectors.","order":1,"name":"Ethics","label":"Disclosure","group":{"name":"EthicsHeading","label":"Ethics"}}]}}